Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(3 sites)

United States

Icahn School of Medicine at Mount Sinai, New York, New York

Ohio State University Comprehensive Cancer Center, Columbus, Ohio

Huntsman Cancer Institute, Salt Lake City, Utah